Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test.

Dulawa SC, Hen R.

Neurosci Biobehav Rev. 2005;29(4-5):771-83. Review.

PMID:
15890403
2.

Effects of chronic fluoxetine in animal models of anxiety and depression.

Dulawa SC, Holick KA, Gundersen B, Hen R.

Neuropsychopharmacology. 2004 Jul;29(7):1321-30.

3.

Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.

Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, Hen R, Belzung C.

Biol Psychiatry. 2008 Aug 15;64(4):293-301. doi: 10.1016/j.biopsych.2008.02.022. Epub 2008 Apr 11.

PMID:
18406399
4.

cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response.

Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, Malberg JE, Blendy JA.

J Neurosci. 2007 Jul 18;27(29):7860-8.

5.

Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?

Consoli D, Leggio GM, Mazzola C, Micale V, Drago F.

Eur J Pharmacol. 2007 Nov 14;573(1-3):139-47. Epub 2007 Jul 4.

PMID:
17669397
6.

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.

Ramamoorthy R, Radhakrishnan M, Borah M.

Behav Pharmacol. 2008 Feb;19(1):29-40. doi: 10.1097/FBP.0b013e3282f3cfd4.

PMID:
18195592
7.

Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test.

Bechtholt AJ, Hill TE, Lucki I.

Psychopharmacology (Berl). 2007 Mar;190(4):531-40. Epub 2006 Dec 13.

PMID:
17165096
8.

Models of anxiety: responses of mice to novelty and open spaces in a 3D maze.

Ennaceur A, Michalikova S, van Rensburg R, Chazot PL.

Behav Brain Res. 2006 Nov 1;174(1):9-38. Epub 2006 Aug 17.

PMID:
16919819
9.

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.

Cryan JF, Mombereau C, Vassout A.

Neurosci Biobehav Rev. 2005;29(4-5):571-625. Review.

PMID:
15890404
10.

Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.

Breuer ME, Groenink L, Oosting RS, Westenberg HG, Olivier B.

Biol Psychiatry. 2007 Apr 15;61(8):990-5. Epub 2006 Dec 4.

PMID:
17141743
11.

Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression.

Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM.

J Pharmacol Exp Ther. 2009 May;329(2):429-38. doi: 10.1124/jpet.108.143362. Epub 2009 Jan 30.

12.

Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats.

Rygula R, Abumaria N, Flügge G, Hiemke C, Fuchs E, Rüther E, Havemann-Reinecke U.

Behav Pharmacol. 2006 Feb;17(1):19-29.

PMID:
16377960
13.

A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.

Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS.

Biol Psychiatry. 2007 Mar 1;61(5):661-70. Epub 2006 Aug 30.

PMID:
16945347
14.

Antidepressant response to chronic citalopram treatment in eight inbred mouse strains.

Jiao J, Nitzke AM, Doukas DG, Seiglie MP, Dulawa SC.

Psychopharmacology (Berl). 2011 Feb;213(2-3):509-20. doi: 10.1007/s00213-010-2140-0. Epub 2010 Dec 22.

PMID:
21181117
15.

Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.

Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K, Matsuda T.

Neuropharmacology. 2008 Dec;55(8):1355-63. doi: 10.1016/j.neuropharm.2008.08.026. Epub 2008 Aug 30.

PMID:
18796307
16.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL.

Psychopharmacology (Berl). 2007 Jun;192(2):159-70. Epub 2007 Feb 13.

PMID:
17297636
17.

Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.

Basso AM, Bratcher NA, Harris RR, Jarvis MF, Decker MW, Rueter LE.

Behav Brain Res. 2009 Mar 2;198(1):83-90. doi: 10.1016/j.bbr.2008.10.018. Epub 2008 Oct 18.

PMID:
18996151
18.

Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats.

Lakhwani L, Tongia SK, Pal VS, Agrawal RP, Nyati P, Phadnis P.

Acta Pol Pharm. 2007 May-Jun;64(3):271-6.

19.

Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice.

Mineur YS, Belzung C, Crusio WE.

Behav Brain Res. 2006 Nov 25;175(1):43-50. Epub 2006 Oct 4.

PMID:
17023061
20.

Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey.

Yalcin I, Belzung C, Surget A.

Behav Brain Res. 2008 Nov 3;193(1):140-3. doi: 10.1016/j.bbr.2008.04.021. Epub 2008 May 2.

PMID:
18565601

Supplemental Content

Support Center